Phenanthrolines protect astrocytes from hemin without chelating iron

Area of Science:

• Neuroscience
• Cell Biology
• Toxicology

Background:

• Hemin, a hemoglobin degradation product, drives neurodegeneration post-hemorrhagic stroke.
• Cellular hemin breakdown releases iron, promoting toxic hydroxyl radical production.

Purpose of the Study:

• To investigate the protective mechanisms of phenanthroline compounds against hemin toxicity in primary mouse astrocytes.
• To determine if chelatable iron or intact hemin is responsible for hemin-induced astrocyte death.

Main Methods:

• Primary mouse astrocyte cultures were treated with hemin (33 μM) and either 1,10-phenanthroline or 4,7-phenanthroline.
• Cell viability, hemin cellular accumulation, hemin degradation, and hemin-hydrogen peroxide interactions were assessed.

Main Results:

• Hemin (33 μM) killed ~75% of astrocytes within 24 hours.
• Both phenanthroline isoforms significantly reduced hemin toxicity; 4,7-phenanthroline provided complete protection at ≥33 μM.
• Reduced toxicity correlated with decreased hemin uptake; hemin degradation remained minimal (~90%) regardless of treatment.
• Cell-free assays showed hemin inactivates hydrogen peroxide, a reaction slowed by phenanthrolines.

Conclusions:

• Chelatable iron is not the primary driver of hemin toxicity in astrocytes.
• Phenanthrolines protect astrocytes by limiting hemin uptake and its interaction with endogenous hydrogen peroxide.
• These findings highlight a novel mechanism of hemin neurotoxicity and potential therapeutic targets.